Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer.
Lists
Only you see this
Abstract
Intensive treatment with gemcitabine-based CRT, high RT dose, and maintenance chemotherapy may improve survival outcomes in locally advanced pancreatic cancer patients receiving neoadjuvant gemcitabine/erlotinib.
BibTeX
@inproceedings{kim2019chemoradiotherapy,
author = {Eunji Kim and Kyubo Kim and Eui Kyu Chie and Do Youn Oh and Young Tae Kim},
title = {{Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer.}},
booktitle = {PubMed},
year = {2019},
}Loading related content...